Former Flex executive Caroline Dowling joins Fabrinet’s board

BANGKOK - Fabrinet (NYSE:FN), a provider of optical packaging and precision manufacturing services, announced Thursday the appointment of Caroline Dowling to its Board of Directors.

Dowling brings over 20 years of experience from Flex, where she most recently served as Business Group President from 2012 until her retirement in February 2019. In that role, she led the company’s Telecommunications, Enterprise Compute, Networking and Cloud Data Centre operations and managed the Global Services Division.

"The breadth and depth of Caroline’s experience will be a significant asset to our Board as we continue to extend our leadership position in the market," said Seamus Grady, Chief Executive Officer of Fabrinet, in a press release statement.

Dowling currently serves on the boards of CRH plc (NYSE:CRH) and DCC plc (LSE:DCC). CRH, with a market capitalization of $79.5 billion, has seen impressive momentum with a 40% gain over the past six months. According to InvestingPro data, analysts maintain a strong buy consensus with price targets ranging from $90 to $152. She previously held a board position at IMI plc from November 2019 to May 2025.

She completed the Harvard Advanced Management Program and holds a Diploma in Environmental, Social & Governance from the Corporate Governance Institute.

Fabrinet provides manufacturing services for complex products including optical communication components, automotive components, medical devices, and industrial lasers. The company maintains facilities in Thailand, the United States, China, and Israel.

In other recent news, CRH plc has completed its $2.1 billion acquisition of Eco Material Technologies, marking a significant expansion into the North American market for Supplementary Cementitious Materials. This acquisition, initially announced in late July, is expected to enhance CRH’s footprint in the concrete production sector. Meanwhile, several investment banks have provided updates on CRH’s stock ratings and price targets. UBS initiated coverage with a Buy rating and a price target of $138, highlighting the company’s strong exposure to US infrastructure. Morgan Stanley reiterated its Overweight rating with a $134 price target, maintaining a positive outlook on the company. RBC Capital raised its price target to $152 from $112, citing a compelling growth outlook shared during CRH’s Capital Markets Day. Additionally, Bernstein SocGen Group reiterated an Outperform rating with a $130 price target, anticipating the Capital Markets Day as a potential catalyst for the stock. These developments reflect a broad confidence among analysts in CRH’s strategic moves and growth prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.